Literature DB >> 12777717

Generation and application of phospho-specific antibodies for p53 and pRB.

Yoichi Taya1, Kiichiro Nakajima, Kumiko Yoshizawa-Kumagaye, Katsuyuki Tamai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12777717     DOI： 10.1385/1-59259-329-1:17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  5 in total

1.  Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage.

Authors:  Yasumichi Inoue; Masatoshi Kitagawa; Yoichi Taya
Journal:  EMBO J       Date:  2007-03-22       Impact factor: 11.598

2.  DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.

Authors:  Koji Okamoto; Kenji Kashima; Yaron Pereg; Michiko Ishida; Satomi Yamazaki; Ayumi Nota; Amina Teunisse; Domenico Migliorini; Issay Kitabayashi; Jean-Christophe Marine; Carol Prives; Yosef Shiloh; Aart G Jochemsen; Yoichi Taya
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

Review 3.  Experimental approaches for investigation of aminoacyl tRNA synthetase phosphorylation.

Authors:  Abul Arif; Jie Jia; Dalia Halawani; Paul L Fox
Journal:  Methods       Date:  2016-10-08       Impact factor: 3.608

4.  Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27.

Authors:  Katia Coulonval; Vincent Vercruysse; Sabine Paternot; Jaime M Pita; Robert Corman; Eric Raspé; Pierre P Roger
Journal:  Cell Cycle       Date:  2021-12-16       Impact factor: 4.534

5.  Distinct and site-specific phosphorylation of the retinoblastoma protein at serine 612 in differentiated cells.

Authors:  Takayuki Hattori; Chiharu Uchida; Hirotaka Takahashi; Naoki Yamamoto; Mikihiko Naito; Yoichi Taya
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.